J KEVIN BUCHI Insider Trading $BSTCE BIOSPECIFICS TECHNOLOGIES CORP

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for J KEVIN BUCHI.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of J KEVIN BUCHI. J KEVIN BUCHI is Chief Executive Officer in BIOSPECIFICS TECHNOLOGIES CORP ($BSTCE) and Director in IMPAX LABORATORIES INC ($IPXL) and Director in ZIOPHARM ONCOLOGY INC ($ZIOP) and Director in EPIRUS Biopharmaceuticals, Inc. ($CRXX) and Director in STEMLINE THERAPEUTICS INC ($STML) and Director in Alexza Pharmaceuticals Inc. ($ALXA) and President & CEO in TETRALOGIC PHARMACEUTICALS CORP ($TLOG) and in Dicerna Pharmaceuticals Inc ($DRNA) and Director in Dicerna Pharmaceuticals Inc ($DRNA) and Director in Amneal Pharmaceuticals, Inc. ($AMRX).

J KEVIN BUCHI in BIOSPECIFICS TECHNOLOGIES CORP

Trading Symbol: BSTCE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of J KEVIN BUCHI: Chief Executive Officer
Holdings: 0 shares
Latest Transaction: Oct 25 2019

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of J KEVIN BUCHI in BIOSPECIFICS TECHNOLOGIES CORP

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ALXA, AMRX, BSTCE, DRNA, CRXX, IPXL, STML, TLOG, ZIOP

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares
Oct 25 2019	BSTCE	BIOSPECIFICS TECHN ...	BUCHI J KEVIN	Chief Executive Off ...	Option Exercise	A	46.52	85,000	3,954,200	85,000
Oct 25 2019	BSTCE	BIOSPECIFICS TECHN ...	BUCHI J KEVIN	Chief Executive Off ...	Option Exercise	A	46.52	85,000	3,954,200	85,000
Oct 25 2019	BSTCE	BIOSPECIFICS TECHN ...	BUCHI J KEVIN	Chief Executive Off ...	Option Exercise	A	46.52	85,000	3,954,200	85,000

Page: 1